Anymore downside to NCM beyond mid $32?

by Raymond Chan

Following my post last week on 27 February entitled" Is NCM likely to try for $36 again this week?", which I said the stock is likely to be "cooling off", which it had this week, but more than cooling off, it lost 5.5%. With this new development in momentum, there has been a change in one of its indicators as well.

NCM closed at $32.57 on 2 Mar 2012

NCM definitely underperformed the market for the week ended 2 Mar 2012. Having lost 5.5% for the week, the question top of mind for investors may be "are there anymore downside?" and "are there any signs of possible turn around yet?"

Let's have a look at options volume first.

Options volume in NCM dropped back down to a more normal level last week. Trading in calls dropped off significantly whilst trading in puts led the stock through out the week as the stock fell. Not a positive turn around sign just yet.

 Implied Volatility (IV)

This is one significant indicator that stood out for me . After staying at a low Implied Volatility of around 24% for about 5 weeks,  it has started to sneak up last week, closing at the highest level of 26.76 in 5 weeks. This makes me uncomfortable. As once IV creeps up from  a low level and is no longer staying flat, it can  threaten to continue to head higher. If that is the direction the IV is heading, from this high 26ish, it can go all the way up to 34. This was the level it rose to end of December last year when NCM fell to a low of $29.60 This is a warning sign for me, especially if its IV would continue to rise in the coming week. $29.60 or there abouts is my target. Stay out or go short for now.

Disclaimer

Information/strategies/trading ideas in this blog is provided for general information purposes only and is not intended as an offer to enter into any transaction. Information contained in this blog is not necessarily complete and its accuracy cannot be guaranteed. Information/strategies/trading ideas here have been prepared without consideration of the investment objectives, financial situation or particular needs of any individual investor. Before a client/investor/reader makes an investment decision, a client/investor/reader should, with or without RBS Morgans' or the author’s assistance, consider whether any advice contained in this blog is appropriate in light of their particular investment needs, objectives and financial circumstances. It is unreasonable to rely on any recommendation without first having spoken to your adviser for a personal recommendation. The use of options may not be suitable for all investors. Potential investors are recommended to seek professional advice before embarking on any strategies mentioned in this blog. The information/strategies/trading ideas contained in this blog have been taken from sources believed to be reliable. Neither the author nor RBS Morgans Limited represent that the information is accurate or complete nor should it be relied upon as such. Any opinions expressed reflect the author’s judgment at this date and are subject to change and is not necessarily that of RBS Morgans'. RBS Morgans and/or its affiliated companies may make markets in the securities discussed. Further, RBS Morgans and/or its affiliated companies and/or their employees from time to time may hold shares, options, rights and/or warrants on any issue included in this blog and may, as principal or agent, sell such securities. The Directors of RBS Morgans Limited and Grosvenor Sydney office advise that they and persons associated with them may have an interest in the above securities and that they may earn brokerage, commissions, fees and other benefits and advantages, whether pecuniary or not and whether direct or indirect, in connection with the making of a recommendation or a dealing by a client/investor/reader in these securities, and which may reasonably be expected to be capable of having an influence in the making of any recommendation, and that some or all of our representatives may be remunerated wholly or partly by way of commission. Information in this blog is proprietary to its author and may not be copied as your own or used for any other purpose without the prior written consent of the author. RBS Morgans Limited (ABN 49 010 669 726 AFSL 235410) A Participant of ASX Group Principal Office: Level 29, Riverside Centre, 123 Eagle Street, Brisbane QLD 4000
 

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?